On April 25, 2019, Mr. Richard T. Schumacher, President and Chief Executive Officer of Pressure BioSciences, Inc. informed the Company's Board of Directors that he plans to step down as President and CEO, effective September 9, 2019. Mr. Schumacher is expected to continue to serve as a member of the Board. After September 9, 2019, Mr. Schumacher is expected to serve as a senior consultant to the Company for at least one year.

On May 1, 2019, the Company announced that the Board has designated Bradford A. Young, Ph.D., MBA to succeed Mr. Schumacher as the Company's President and CEO, effective September 9, 2019. Dr. Young has been the Company's Senior Vice President and Chief Commercial Officer since November 2018.